Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. Shareholder Equity 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cyclerion Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 9.1M, a 2.66% increase year-over-year.
- Cyclerion Therapeutics Inc. shareholder equity for 2025 were 9.1M, a 2.66% increase from 2024.
- Cyclerion Therapeutics Inc. shareholder equity for 2024 were 8.8M, a 21.60% decrease from 2023.
- Cyclerion Therapeutics Inc. shareholder equity for 2023 were 11.3M, a 8.00% increase from 2022.
- Cyclerion Therapeutics Inc. shareholder equity for 2022 were 10.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cyclerion Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $9 |
| 2024 | $9 |
| 2023 | $11 |
| 2022 | $10 |
| 2021 | $48 |
| 2020 | $59 |
| 2019 | $98 |
| Cyclerion Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $9 |
| 2024-12-31 | $9 |
| 2023-12-31 | $11 |
| 2022-12-31 | $10 |
| 2021-12-31 | $48 |
| 2020-12-31 | $59 |
| 2019-12-31 | $98 |
Cyclerion Therapeutics Inc. Shareholder Equity — FAQ
Cyclerion Therapeutics Inc. (CYCN) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYCN's shareholder equity history?
The chart and table above show Cyclerion Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.